State of Alaska Department of Revenue’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-28,393
| Closed | -$266K | – | 1685 |
|
|
2020
Q3 | $266K | Sell |
28,393
-3,070
| -10% | -$29.2K | ﹤0.01% | 1470 |
|
|
2020
Q2 | $240K | Hold |
31,463
| – | – | ﹤0.01% | 1495 |
|
|
2020
Q1 | $194K | Buy |
31,463
+5,855
| +23% | +$51.6K | ﹤0.01% | 1449 |
|
|
2019
Q4 | $311K | Sell |
25,608
-446
| -2% | -$4.87K | ﹤0.01% | 1475 |
|
|
2019
Q3 | $300K | Buy |
26,054
+14,573
| +127% | +$153K | ﹤0.01% | 1454 |
|
|
2019
Q2 | $114K | Sell |
11,481
-220
| -2% | -$2.37K | ﹤0.01% | 1570 |
|
|
2019
Q1 | $150K | Buy |
11,701
+120
| +1% | +$1.79K | ﹤0.01% | 1529 |
|
|
2018
Q4 | $175K | Buy |
11,581
+260
| +2% | +$4.95K | ﹤0.01% | 1463 |
|
|
2018
Q3 | $226K | Buy |
11,321
+100
| +0.9% | +$2.28K | ﹤0.01% | 1469 |
|
|
2018
Q2 | $218K | Buy |
11,221
+160
| +1% | +$3.54K | ﹤0.01% | 1465 |
|
|
2018
Q1 | $222K | Buy |
11,061
+4,020
| +57% | +$68K | ﹤0.01% | 1375 |
|
|
2017
Q4 | $93K | Buy |
7,041
+100
| +1% | +$1.51K | ﹤0.01% | 1526 |
|
|
2017
Q3 | $128K | Buy |
6,941
+70
| +1% | +$1.3K | 0.01% | 1126 |
|
|
2017
Q2 | $126K | Buy |
6,871
+3,081
| +81% | +$61K | 0.01% | 1045 |
|
|
2017
Q1 | $85K | Buy |
3,790
+90
| +2% | +$2.15K | 0.01% | 998 |
|
|
2016
Q4 | $128K | Buy |
+3,700
| New | +$111K | 0.01% | 572 |
|
State of Alaska Department of Revenue's AMAG Position: Q4 2020 in Review
State of Alaska Department of Revenue sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 28,393 shares — an estimated $266K sold.
State of Alaska Department of Revenue first reported a position in AMAG in Q4 2016 and held it in 16 quarters. The position peaked at $311K in Q4 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- State of Alaska Department of Revenue reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- State of Alaska Department of Revenue sold 28,393 AMAG Pharmaceuticals shares in Q4 2020, an estimated $266K.
- State of Alaska Department of Revenue first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 16 quarters.
- State of Alaska Department of Revenue's AMAG Pharmaceuticals position peaked at $311K in Q4 2019.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on State of Alaska Department of Revenue's 13F filing for Q4 2020, filed 8 Jan 2021.